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Background and objectives: Supraglottic airway devices are increasingly used as an option to 
tracheal intubation for elective procedures of varying complexity. The aim of this study was 
to prospectively evaluate the clinical use of the laryngeal mask airway Supreme® (LMAS) in 
patients undergoing elective breast surgery and compare it with endotracheal tube (ETT).
Methods: Sixty patients undergoing breast procedures under general anesthesia were randomly 
divided into two groups according to the device used (LMAS or ETT). Time of insertion, 
number of insertion attempts, hemodynamic response to insertion, presence of blood on the 
device used; and incidence of sore throat, dysphagia, nausea and vomiting were assessed 
postoperatively.
Results: There was no difference between groups regarding time of insertion, number of 
attempts for successful insertion, and presence of blood on the device. Heart rate and blood 
pressure after insertion were higher in ETT group. Incidence of sore throat and dysphagia was 
also higher in ETT group after two hours in the postoperative period. There was no difference 
regarding incidence and severity of complications evaluated after six hours postoperatively.
Conclusions: The use of the LMAS technique to access airway during general anesthesia for 
elective breast surgery is as safe and effective as tracheal intubation, with the advantage of 
promoting smaller hemodynamic response during its management and lower incidence of sore 
throat and dysphagia in the first hours after surgery.
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
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Introduction
Tracheal intubation has been for years the technique of 
choice for airway management during surgical procedures 
under general anesthesia. However, it is not a procedure 
without risk. Complications related to tracheal intubation 
range from events such as tracheal stenosis to other minor 
events, such as hoarseness and sore throat.1-3
Supraglottic devices have a number of advantages over 
endotracheal tube (ETT), as they do not require the use 
laryngoscope for insertion, are less invasive and result in 
less hemodynamic response and airway manipulation.
The laryngeal mask airway Supreme® (LMAS) is a single-
use supraglottic airway device that allows functional 
separation of the respiratory and digestive systems because 
it has an accessory channel for gastric content drainage. 
It has an anatomical shape, angled and semi-rigid, which 
facilitates its insertion (without digital guidance), and a 
differentiated cuff, which gives it a high pressure seal and 
better performance during mechanical ventilation.4,5 The 
aim of this randomized, prospective clinical trial was to 
evaluate the use of LMAS in elective breast surgery and 
compare it with endotracheal tube.
Method
With the Research Ethics Committee approval and informed 
consent signed, 60 patients undergoing elective breast 
surgery (silicone prostheses implantation, lumpectomy, 
mastectomy and setorectomy) were selected for this trial 
between August and December, 2010. Inclusion criteria were 
age between 18 and 60 years, body mass index (BMI) below 
30 kg•m–2, and physical status P-I or II (according to the 
classification of the American Society of Anesthesiologists). 
Exclusion criteria were patients with suspected difficult 
airway, mouth opening less than 3 cm or increased risk of 
aspiration.
Patients were randomly divided into two groups based 
on a table of random permutations generated by computer. 
ETT and LMAS groups, with 30 patients each, were classified 
according to the airway device used: endotracheal tube 
(size 7.5) or cuffed laryngeal mask airway Supreme® (size 
4), respectively. 
At the operating room, all patients received 
intravenous midazolam (2 mg) as premedication after 
venoclysis. Standard monitoring was performed wit 
cardioscopy, non-invasive measurements of blood 
pressure, pulse oximetry, and capnography. Induction 
of anesthesia was performed with fentanyl (3 μg•kg–1), 
propofol (2.5 mg•kg–1), and atracurium (0.5 mg•kg–1). 
After manual ventilation under face mask for 3 minutes, 
the airway device was inserted. Laryngeal mask airway 
was inserted after totally deflated and lubricated on 
its posterior surface with hydrophilic gel. Insertion was 
done according to the manufacturer’s instructions by 
the anesthesiologist responsible for the case under the 
supervision of the researcher, a proficient physician in 
the use of the technique in question. Endotracheal tube 
was inserted through a conventional laryngoscopy with 
a curved Macintosh blade, number 3 or 4. The device 
cuff was inflated up to 30 cmH2O for endotracheal tube 
and up to 60 cmH2O for laryngeal mask airway, which 
were confirmed by a manometer. Insertion success was 
confirmed by visible thoracic expansion and identification 
of capnography curve. The correct positioning of the 
laryngeal mask was then confirmed by the absence of 
air leakage through the gastric access channel during 
ventilation (bubble test) and passage without resistance 
of a gastric tube (size 14) lubricated with hydrophilic 
gel through the same channel.6,7 Placement testing was 
not recorded at the time of mask insertion. However, 
if a test indicated a bad position, the mask would be 
withdrawn and the insertion considered a failure. 
A gastric tube was also inserted through the oropharynx 
in patients of ETT group, and after gastric content initial 
aspiration, it was kept open for free drainage in both groups. 
Mechanical ventilation was performed in PCV mode and 
ventilatory parameters adjusted to ensure minimum tidal 
volume of 7 mL•kg–1, ETCO2 below 45, and O2 saturation 
above 95%.
Parameters recorded insertion time (time interval 
between the beginning of insertion and registration of the 
first capnography curve), number of successful attempts 
for insertion, hemodynamic response to insertion (heart 
rate and mean arterial pressure 30 seconds before and 
immediately after insertion confirmation), and presence of 
blood on device used (laryngoscope, in case of intubation, 
and laryngeal mask itself at the end of the procedure). In 
case of laryngeal mask insertion failure after a maximum 
of two attempts, the device would be replaced by an 
endotracheal tube. The insertion attempt was considered 
a failure when the device was removed from the patient’s 
mouth before being reinserted again. Small interventions 
such as head and neck adjustment or change in depth 
of mask insertion were allowed to obtain satisfactory 
ventilation. The time of these interventions was recorded 
at insertion time. 
Intravenous dexamethasone (4 mg) was used as prophylaxis 
after induction of anesthesia. Neuromuscular blockade was 
reversed at the end of surgery with the use of atropine (0.01 
mg•kg–1) and neostigmine (0.03 mg•kg–1). After recovery of 
spontaneous ventilation and eye opening, the device used 
was removed. Analgesia included intravenous dipyrone 
(2 g) and Ketoprofen (100 mg) during surgery and dipyrone 
(1 g/every 6 hours) and ketoprofen (100 mg/every 12 hours) 
after surgery.
All patients were reassessed at 2 and 6 hours after the 
procedure by an observer, who was blind to the device used 
intraoperatively, for presence of neck pain, episodes of 
nausea and vomiting, and dysphagia (difficulty swallowing 
saliva). The intensity of neck pain and dysphagia were 
evaluated based on a numerical scale from 0 to 10, in which 
0 = no pain and 10 = the worst pain possible.
Continuous data were first analyzed for normality 
using the KS distance test and expressed as mean and 
standard deviation (parametric) or median and percentile 
(nonparametric). For data comparison of two independent 
samples, the unpaired Student’s t-test was used for 
parametric data and Mann-Whitney test for nonparametric 
data. Chi-square test was used for independent variables 
in categorical data evaluation and data were expressed as 
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Table 1 Demographic data according to groups.
 ETT (n = 30) LMAS (n = 30) p
Age (years) 34 (23-51) 30 (24-45) 0.684
BMI (Kg•m–2) 21.4 (20.4-22.8) 21.4 (20.2-26.1) 0.856
BMI, body mass index; ETT, endotracheal tube; LMAS, laryngeal mask airway Supreme.
Data are expressed as median (25-75 percentiles) or number (percentage).
Table 2 Data regarding device insertion according to groups.
 ETT (n = 30) LMAS (n = 30) p
Insertion attempts (n)   1.000
One 28 (93.3%) 27 (90%) 
Two 2 (6.7%) 3 (10%)
Insertion time (sec) 48.4 ± 23.2 38.7 ± 21.5 0.102
ETT, endotracheal tube; LMAS, laryngeal mask airway Supreme; n, number; sec, seconds.
Data are expressed as number (percentage) or mean ± standard deviation.
Table 3 Hemodynamic variables before and after insertion according to groups.
 Before insertion After insertion
 ETT (n = 30) LMAS (n = 30) p ETT (n = 30) LMAS (n = 30) p
HR; bpm 68 ± 9.1 69 ± 10.5 0.63 81.6 ± 13.3 71.4 ± 11 0.002
SBP; mmHg 95.5 ± 16.7 96 ± 15.8 0.756 121.8 ± 15.9 101.5 ± 16.4  < 0.001
DBP; mmHg 51 ± 13.2 50.7 ± 13.1 0.847 73.7 ± 12.5 56.7 ± 13.5 < 0.001
MAP; mmHg 68 ± 14.8 68.4 ± 13.8 0.976 92.4 ± 16 74 ± 14.1 < 0.001
bpm, beats per minute; DBP, diastolic blood pressure; ETT, endotracheal tube; HR, heart rate; LMAS, laryngeal mask airway 
Supreme; MAP, mean arterial pressure; SBP, systolic blood pressure.
Data are expressed as mean ± standard deviation.
absolute frequency and percentage. Throughout the study, 
an alpha risk < 5% was used for Type-I or first kind error.
Results
Demographic data of patients included in the study are 
shown in Table 1.
The device was successfully inserted at first attempt in 
90% of cases in LMAS group and in 93.3% of cases in ETT 
group (p = 1.000). There was no difference between groups 
regarding time of insertion. There was presence of blood in 
only one case in LMAS group and none in ETT group. Data 
on insertion are shown in Table 2.
Hemodynamic variables assessed before insertion were 
similar in both groups. However, in the post-insertion 
period, ETT group had increased values of heart rate, 
systolic, diastolic and mean blood pressure, compared 
to the LMAS group, as shown in Table 3. There was no 
failure or complication in either group during mechanical 
ventilation.
The incidence of sore throat and dysphagia 2 hours after 
surgery was higher in ETT group (p < 0.005). There was no 
difference regarding incidence and severity of complications 
assessed in both groups 6 hours after surgery. Table 4 shows 
the distribution of complications found at 2 and 6 hours 
after surgery. 
Discussion
This study demonstrated that laryngeal mask airway 
Supreme® safely and effectively replaces endotracheal 
tube for airway control during general anesthesia in 
breast surgical procedures. There is a growing interest 
of anesthesiologists in less invasive techniques for airway 
access. A census taken recently in the UK involving 309 
hospitals of the public health system showed that 56.2% 
of the surgical procedures under general anesthesia were 
performed with a supraglottic airway device.8 This is a 
marked change in paradigm that tracheal intubation is 
the most appropriate technique to ensure a patent airway 
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Table 4 Postoperative complications after 2 and 6 hours according to groups.
 2 hours  6 hours
 ETT (n = 30) LMAS (n = 30) p ETT (n = 30) LMAS (n = 30) p
Dysphagia   0.001   0.136
Absent (NS = 0) 21 (70%) 30 (100%)  24 28 (93.4%) 
Mild (NS = 1-3) 8 (26.7%) 0  6 1 (3.3%) 
Moderate (NS = 4-7) 1 (3.3%) 0  0 1 (3.3%) 
Severe (NS = 8-10) 0 0  0 0 
Sore throat   0.02   0.143
Absent (NS = 0) 23 (76.7%) 29 (96.7%)  24 (80%) 28 (93.4%) 
Mild (NS = 1-3) 6 (20%) 1 (3.3%)  5 (16.7%) 1 (3.3%) 
Moderate (NS = 4-7) 1 (3.3%) 0  1 0 
Severe (NS = 8-10) 0 0  0 1 (3.3%) 
Nausea   0.797   0.218
Absent 24 (80%) 24 (80%)  19 (63%) 24 (80%) 
Present 6 (20.7%) 6 (20.7%)  11 (38%) 6 (20%) 
Vomiting   0.976   0.580
Absent 28 (93%) 29 (96%)  27 (90%) 29 (96%) 
Present 2 (6.9%) 1 (3.3%)  3 (10.3%) 1 (3.3%)
TT, endotracheal tube; HR, heart rate; LMAS, laryngeal mask airway Supreme.
Data are expressed as number (percentage). Nausea and vomiting are recorded as present/absent. Dysphagia and sore throat are 
registered according to intensity assessed on a pain numerical scale (NS) from 0 to10.
during positive pressure ventilation and, especially, during 
elective surgical procedures.
Endotracheal tube replacement by a laryngeal mask 
airway as a primary device to provide ventilation during 
general anesthesia is a trend that has gained strength 
before the breakthrough of this category of devices in the 
last decade and benefits of avoiding airway manipulation. 
The LMAS insertion technique is simple, exempting the 
use of aid tools and success, both in the insertion and 
maintenance of ventilation, is equivalent to the standard 
technique (intubation), as shown by the results of this 
study.
Since its invention in the early 1980s, laryngeal mask 
airway has undergone design changes. The incorporation of 
a gastric channel access, present in LMAS, probably was the 
innovation of greatest impact on its functionality.9,10 This 
channel presence allows the functional separation between 
gastrointestinal and respiratory tracts. Furthermore, through 
this channel it is possible to do a series of tests to confirm 
the device correct positioning after insertion.6,7 Changes in 
laryngeal mask and cuff format made the device seal more 
efficient, improving its performance during mechanical 
ventilation and allowing tracheal tube replacement in 
procedures of varying complexity.11,12 This study shows that 
mechanical ventilation is satisfactorily maintained with the 
LMAS throughout surgery, despite transient changes that 
may occur in chest complacency resulting from surgical 
manipulation and other factors.
A meta-analysis of 29 randomized prospective clinical 
trials showed that patients undergoing general anesthesia 
with laryngeal mask airway are less likely to develop 
hoarseness, coughing, and laryngospasm during emergence 
from anesthesia compared to patients undergoing tracheal 
intubation.13 Our study also showed a higher incidence of 
sore throat and dysphagia in patients with endotracheal 
tube in the first 2 hours after surgery. This finding is 
probably related to characteristics inherent to the 
airway access technique used, as the presence of blood 
in the devices, here interpreted as an indirect sign of a 
traumatic manipulation, could not justify the incidence 
of these complications in the postoperative period, as 
it was a rare occurrence observed precisely in the LMAS 
group in which the incidence of sore throat and dysphagia 
was lower.
Postoperative nausea and vomiting (PONV) are common 
complications frequently found in patients undergoing 
general anesthesia and of particular concern in the context 
of outpatient procedures, as it end up being responsible 
for much of the unanticipated hospitalizations in this group 
of patients. Although several authors have attempted 
to correlate the technique of airway control with these 
complications, the results are highly variable.13-15 This study 
further evidences that the incidence of PONV probably is 
not affected by the chosen device for airway access, as this 
incidence was very low and not correlated with the device 
used. The hemodynamic response triggered by tracheal 
intubation is much more intense compared to that of 
laryngeal mask insertion, as shown by our results. This fact 
is probably related to the increased airway manipulation 
during tracheal intubation through direct laryngoscopy. This 
greater intensity in hemodynamic response also correlates 
with the increased release of catecholamines and may be 
of concern in patients with reduced cardiovascular reserve 
or high cardiac risk.16,17
It should be emphasized that this study was limited 
to the evaluation of a very specific population: female 
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patients without relevant comorbidities and undergoing 
simple and relatively small surgical procedures. This makes 
it impossible to extrapolate the results obtained for male 
patients or more complex and longer procedures or even 
those performed in positions other than supine. Moreover, 
the routine use of analgesics and anti-inflammatory drugs 
postoperatively may have affected the assessment of some 
postoperative complications, such as dysphagia and sore 
throat in the period after 6 hours. The intensity of these 
complications may have been tempered by the effect of 
these agents. 
Given the results presented, we conclude that LMAS as 
a technique of airway access during general anesthesia for 
elective breast surgery proved to be as safe and efficient 
as tracheal intubation, with the advantage of attenuating 
hemodynamic response during its execution and reducing 
the incidence of sore throat and dysphagia in the first hours 
of the postoperative period.
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